Top Story

Acceleration of cognitive decline occurs after incident stroke

Acceleration of cognitive decline occurs after incident stroke
July 7, 2015

Individuals who survive a stroke are more likely to experience severe decline in cognitive function following their stroke, along with accelerated and persistent cognitive decline in the 6 years following stroke, according to recently released data in JAMA.

“In this national cohort of black and white U.S. residents 45 years or older, incident stroke was associated with accelerated and persistent declines in global cognition and executive function, after accounting for individuals’ cognitive changes before and acutely after the event,” Deborah A. Levine, MD, MPH, Division of General Medicine, University of Michigan, and colleagues wrote.

In the Journals

Extended anticoagulation beneficial after pulmonary embolism; stops when treatment ends

July 7, 2015
Patients who experience a first pulmonary embolism may benefit from anticoagulation therapy for up to 2 years after the unprovoked episode, although the benefits of…
In the Journals

Daytime traffic noise exposure may raise mortality risk

July 7, 2015
Long-term exposure to a greater amount of road traffic noise was associated with a small but significant increased risk for mortality and stroke-related hospitalization…
Trial Scorecards

Trial Scorecard: EXACT-HF

Cardiology Today, July 2015
Study of effectiveness of allopurinol for relieving symptoms in patients with HF and high blood uric acid levels.
FDA NewsPublication Exclusive

FDA advisory panel backs approval of PCSK9 inhibitors

Cardiology Today, July 2015
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted in June to recommend approval of two PCSK9 inhibitors for the reduction of LDL in certain…
More News Headlines »
CME
Antiplatelet Agents in ACS Distinguishing Characteristics Safety and Efficacy

Antiplatelet Agents in ACS: Distinguishing Characteristics, Safety, and Efficacy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
Meeting News Coverage Video
VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

June 28, 2015
NEW ORLEANS – Joseph Ho, PharmD, clinical pharmacist with Ochsner Baptist Medical Center in New Orleans…
More »
Antiplatelet Therapy in ACS and PCI

Antiplatelet Therapy in ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
morganatic-roan
morganatic-roan